COMPANY

ProDa BioTech, LLC

HQ: Marietta, GA source

Location: Marietta, GA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $1.14M (SBIR Phase II 1R44CA314813-01, new, notice Sep 4, 2026). NIH RePORTER 1R44CA314813-01 (Sep 4, 2026)
Evidence (1 event)
- Sep 4, 2026 · NIH RePORTER 1R44CA314813-01
  Organization: PRODA BIOTECH, LLC; City/State: MARIETTA, GA; Project number: 1R44CA314813-01; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-09-04; FY total cost (award amount): 1139113; Administering IC: National Cancer Institute; Project title: Development of a new combination therapy for pancreatic ductal adenocarcinoma treatment; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals